Role of GABAA/benzodiazepine receptors containing α1 and α5 subunits in the discriminative stimulus effects of triazolam in squirrel monkeys

Psychopharmacology

Volumn 161, Issue 2, 2002, Pages 180-188

  Lelas, Snjezana ^a,c,d   Rowlett, James K ^a,c,d   Spealman, Roger D ^a,c,d   Cook, James M ^b,c,d   Ma, Chunrong ^b,c,d   Li, Xiaoyan ^b,c,d   Yin, Wenyuan ^b,c,d  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF WISCONSIN MILWAUKEE   (United States)

^c BRISTOL MYERS SQUIBB   (United States)

^d PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

CCT antagonism; Drug discrimination; Schild analysis; Squirrel monkey; Triazolam

Indexed keywords

3 METHYL 6 (3 TRIFLUOROMETHYLPHENYL) 1,2,4 TRIAZOLO[4,3 B]PYRIDAZINE; 4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID A RECEPTOR STIMULATING AGENT; BENZODIAZEPINE RECEPTOR; BETA CARBOLINE 3 CARBOXYLIC ACID TERT BUTYL ESTER; BETA CARBOLINE DERIVATIVE; QH II 66; RECEPTOR SUBUNIT; TRIAZOLAM; UNCLASSIFIED DRUG; ZALEPLON; ZOLPIDEM; 3 PROPOXY BETA CARBOLINE; 3-PROPOXY-BETA-CARBOLINE; 4 AMINOBUTYRIC ACID RECEPTOR BLOCKING AGENT; 4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; ANXIOLYTIC AGENT; BENZODIAZEPINE RECEPTOR AFFECTING AGENT; CARBOLINE DERIVATIVE; TERT-BUTYL BETA-CARBOLINE-3-CARBOXYLATE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DRUG DISCRIMINATION; DRUG EFFECT; DRUG RECEPTOR BINDING; EVALUATION; MALE; NONHUMAN; PRIORITY JOURNAL; REINFORCEMENT; SQUIRREL MONKEY; STIMULUS RESPONSE; ANIMAL; CEBIDAE; DOSE RESPONSE; DRUG POTENTIATION; PERCEPTIVE DISCRIMINATION; PHYSIOLOGY; REACTION TIME; STATISTICAL MODEL;

ANIMALS; ANTI-ANXIETY AGENTS; CARBOLINES; DISCRIMINATION (PSYCHOLOGY); DOSE-RESPONSE RELATIONSHIP, DRUG; GABA AGONISTS; GABA ANTAGONISTS; GABA MODULATORS; MALE; MODELS, STATISTICAL; REACTION TIME; RECEPTORS, GABA-A; SAIMIRI; TRIAZOLAM;

EID: 0036012807     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-002-1037-y     Document Type: Article

References (39)

1. High-dose discrimination training with midazolam: Context determines generalization profile
2. Zaleplon and triazolam: Drug discrimination, plasma levels, and self-administration in baboons
3. Discriminative stimulus effects of atypical anxiolytics in baboons and rats
4. Asymmetrical cross-generalization with lorazepam and pentobarbital training conditions
5. Selectivity in generalization profile in baboons trained to discriminate lorazepam: Benzodiazepines, barbiturates and other sedative/hypnotics
6. Differentiating benzodiazepine- and barbiturate-like discriminative stimulus effects of lorazepam, diazepam, pentobarbital, imidazenil and zaleplon in two- versus three-lever procedures
7. Pharmacologic effects and abuse liability of bretazenil, diazepam, and alprazolam in humans
8. CNS-neurological models of disease: Substance abuse, self-administration in monkeys
9. A receptors different from zolpidem, zopiclone and benzodiazepines
10. A receptors
11. Discriminative stimulus properties of midazolam in the pigeon
12. Zolpidem and triazolam in humans: Behavioral and subjective effects and abuse liability
13. Discriminative stimulus properties of CL 218,872 and chlordiazepoxide in the rat
14. CL 218872 antagonism of diazepam induced loss of righting reflex: Evidence for partial agonistic activity at the benzodiazepine receptor
15. Benzodiazepine self-administration in humans and laboratory animals: Implications for problems of long-term use and abuse
16. Zolpidem behavioral pharmacology in baboons: Self-injection, discrimination, tolerance and withdrawal
17. A/BzR subtypes (α1β3γ2, α5β3γ2, and α6β3γ2) via a comprehensive ligand-mapping approach
18. A receptors containing α5 subunits in the CA1 and CA3 hippocampal fields regulate ethanol-motivated behaviors: An extended ethanol reward circuitry
19. GABA(A)-receptor subtypes: Clinical efficacy and selectivity of benzodiazepine site ligands
20. Discriminative stimulus effects of the novel 1,4-benzodiazepine QH-ii-66 in ethanol- and triazolam-trained squirrel monkeys
21. Using behavior to elucidate receptor mechanisms: A review of the discriminative stimulus effects of benzodiazepines
22. Triazolam discrimination in squirrel monkeys distinguishes high-efficacy agonists from other benzodiazepines and non-benzodiazepine drugs
23. Isobolographic analysis of chlordiazepoxide and triazolam combinations in squirrel monkeys discriminating triazolam
24. Generalization between benzodiazepine- and triazolopyridazine-elicited discriminative cues
25. Binding and neuropharmacological profile of zaleplon, a novel nonbenzodiazepine sedative/hypnotic
26. A/α1 receptors
27. A receptor subtypes: Dissecting their pharmacological functions
28. Discriminative stimulus effects of triazolam, zolpidem, oxazepam and caffeine in humans
29. The discriminative stimulus properties of zolpidem, a novel imidazopyridine hypnotic
30. Comparison of the pharmacological profiles of the hypnotic drugs, zaleplon and zolpidem
31. A receptors: Differential profiles and receptor selectivity
32. Beta-carboline-3-carboxylate-t-butyl ester: A selective BZ1 benzodiazepine receptor antagonist
33. Beta-carbolines as antagonists of the discriminative stimulus effects of diazepam in rats
34. A receptors containing α5 subunits
35. Discriminative-stimulus effects of midazolam in squirrel monkeys: Comparison with other drugs and antagonism by Ro 15-1788
36. Evaluation of the discriminative stimulus effects of the novel sedative hypnotic CL 284,846
37. A receptor subtypes